Evidence map›Paper›PMID 40775239›Full record

ArticleNPJ biofilms and microbiomes2025

Mobiluncus mulieris alters the transcriptomic profile of cervicovaginal epithelial cells, shedding light on molecular drivers of adverse reproductive outcomes.

Yu Hasegawa, Olivia Swain, Urvija Rajpal, Michael T France, Liqhwa Ncube, Haocheng Yu, Ilaria Mogno, Amir Horowitz, Jacques Ravel, Michal A Elovitz

Abstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Evaluating theFrontiers in immunology · 2026
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yu HasegawaWomen's Biomedical Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. yu.hasegawa@mssm.edu.
Olivia SwainWomen's Biomedical Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Urvija RajpalDepartment of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Michael T FranceCenter for Advanced Microbiome Research and Innovation (CAMRI), Institute for Genome Sciences, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Liqhwa NcubeWomen's Biomedical Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Haocheng YuDepartment of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ilaria MognoDepartment of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Amir HorowitzDepartment of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Jacques RavelCenter for Advanced Microbiome Research and Innovation (CAMRI), Institute for Genome Sciences, and Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Michal A ElovitzNuttall Women's Health, New York, NY, USA.

Funding

The role of host-microbial interactions in altering preterm birth risk among black womenR01NR014784 · NINR · UNIVERSITY OF PENNSYLVANIA · PI ELOVITZ, MICHAL AVIVA · 2013 to 2024
$6.4M
Deciphering the Role of Vaginal Microbes in Preterm birthR01HD102318 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI ELOVITZ, MICHAL AVIVA · 2020 to 2024
$3.4M
Unraveling mechanisms by which cervicovaginal microbiota can promote or prevent cervical remodeling and preterm birthR01HD098867 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI ELOVITZ, MICHAL AVIVA · 2020 to 2024
$2.9M
National Institute for Nursing Research of the National Institutes of Health R01NR014784National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) R01HD098867NICHD NIH HHS R01 HD098867NICHD NIH HHS R01 HD102318NINR NIH HHS R01 NR014784
6 · The paper itself

Abstract

The vaginal microbiota is critical for reproductive health, and its disruption, particularly the loss of Lactobacillus spp. and dominance of anaerobes such as Mobiluncus mulieris (community state type IV, CST IV), is associated with bacterial vaginosis, sexually transmitted infections, and adverse reproductive outcomes, including preterm birth (PTB). While Gardnerella spp. have been widely studied, the role of M. mulieris remains poorly understood. This study used an unbiased discovery approach to examine host-microbe interactions driven by M. mulieris across distinct epithelial barriers of the lower reproductive tract. RNA sequencing revealed that live bacteria, cell-free supernatant, and bacterial extracellular vesicles (bEVs) each induced unique transcriptional responses in epithelial cells. All three components activated immune and inflammatory pathways, with bEVs eliciting the strongest response, particularly via toll-like receptor (TLR) 2 and TLR5 signaling. M. mulieris also altered extracellular matrix (ECM) remodeling pathways, including upregulation of matrix metalloproteinase 9 (MMP9), a key mediator linked to PTB. These findings were supported by clinical data showing elevated MMP9 in pregnant women with M. mulieris-containing vaginal microbiota. Collectively, these results highlight the broad impact of M. mulieris on epithelial responses and identify mechanisms by which specific anaerobes contribute to inflammation and ECM disruption in adverse reproductive outcomes.

Indexed as

Cervix UteriEpithelial CellsTranscriptomeVaginaExtracellular VesiclesFemaleGene Expression ProfilingHost Microbial InteractionsHumansMatrix Metalloproteinase 9MicrobiotaPregnancyPremature BirthVaginosis, BacterialMatrix Metalloproteinase 9

Identifiers

PMID40775239
PMCPMC12331918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.